Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand

International Journal of Clinical Pharmacy

Volumn 35, Issue 4, 2013, Pages 608-612

  Tiamkao, Somsak ^a   Jitpimolmard, Jukrapope ^a   Sawanyawisuth, Kittisak ^a   Jitpimolmard, Suthipun ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Carbamazepine; Cost effectiveness; Epidermal Necrolysis; HLA B*1502; Screening; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; HLA B ANTIGEN; HLA B1502 ANTIGEN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN;

ADULT; ALLELE; ANTIGEN DETECTION; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DISEASE ASSOCIATION; DRUG COST; EPILEPSY; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; THAILAND; TOXIC EPIDERMAL NECROLYSIS;

ALLELES; ANTICONVULSANTS; CARBAMAZEPINE; COST-BENEFIT ANALYSIS; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HLA-B15 ANTIGEN; HUMANS; PREVALENCE; STEVENS-JOHNSON SYNDROME; THAILAND;

EID: 84881126883     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9777-9     Document Type: Article

References (13)

1. Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor. Malays Int J Dermatol. 2010;49(7):834-41.
2. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;16(5):39.
3. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428(6982):486. (Pubitemid 38480527)
4. Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol. 2010;67(9):885-7.
5. Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. 2008;49(12):2087-91.
6. Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia. 2010;51(5):926-30.
7. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Eng J Med. 2011;364(12):1126-33.
8. Chang CC, Too CL, Murad S, Hussein SH. (2011) Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multiethnic Malaysian population. Int J Dermatol. 2011;50(2):221-4.
9. Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLAB*1502 allele among patients in central China. Epilepsy Behav. 2010;19(3):405-8.
10. Romphruk AV, Romphruk A, Kongmaroeng C, Klumkrathok K, Paupairoj C, Leelayuwat C. HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens. 2010;75(6):701-11.
11. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49(2):542-6. (Pubitemid 27368898)
12. Locharernkul C, Shotelersuk V, Hirankarn N. HLA-B*1502 screening: time to clinical practice. Epilepsia. 2010;51(5):936-8.
13. Thavichachart N, Intoh P, Thavichachart T, Meksupa O, Tangwongchai S, Sughondhabirom A. Epidemiological survey of mental disorders and knowledge attitude practice upon mental health among people in Bangkok Metropolis. J Med Assoc Thai. 2001;84(S1):S118-26.